Life Insurance
Consensus Index

AI Consensus Fit Review

Aetna Final Expense Insurance Fit Review for People With Diabetes

Aetna is a good, case-dependent fit for a senior with diabetes seeking roughly $15,000–$25,000 of permanent final expense coverage through its Accendo Final Expense Whole Life product.

Research: 2026-09-227 usable platform responsesRead the methodology ↗

Share

Answer Capsule

Aetna is a good, case-dependent fit for a senior with diabetes seeking roughly $15,000–$25,000 of permanent final expense coverage through its Accendo Final Expense Whole Life product. Four of seven platforms named Aetna during the ranking stage, with an average listed rank of 2.75 and a best rank of 1. The strongest reason to consider it is simplified-issue underwriting that several platforms describe as relatively favorable for controlled diabetes, including insulin use, with a possible Modified fallback. The main limitation is that no public source verifies current diabetes-specific acceptance rules or pricing, so approval and tier assignment remain uncertain until Aetna underwrites the application.

Research Snapshot

FieldFinding
Platform mentions in ranking stage4 of 7 platforms (anthropic, deepseek, grok, kimi)
Share of included platform responses57.1%
Average listed rank2.75
Best listed rank1
Relevant product/model/planAccendo Final Expense Whole Life Insurance, including Level/Preferred, Standard, and Modified benefit options
Overall use-case fitGood, but case-dependent; one platform rated it mixed
Research date2026-09-22

Why Aetna Qualified for This Study

Questions This Section Answers

  • Why did Aetna qualify for this final expense insurance study for people with diabetes?
  • How many AI platforms named Aetna for final expense coverage with diabetes?

Aetna qualified because four of the seven included platforms named it during ranking discovery for a senior with diabetes seeking $15,000–$25,000 of permanent final expense coverage [1]. Its listed ranks ranged from 1 to 4, producing an average of 2.75 and a best rank of 1. The platform that ranked it first was anthropic; deepseek and kimi placed it third, and grok placed it fourth.

The entity that actually appears in the ranking is the carrier Aetna, but the product most platforms discuss is Accendo Final Expense Whole Life, marketed under Aetna-related branding. Independent reviews state that Accendo Insurance Company is a wholly-owned subsidiary of Aetna, which is owned by CVS Health [5]. One platform notes that Aetna Senior Products comprises two issuing companies, Continental life insurance Company of Brentwood, TN, and Accendo Insurance Company, both rated "A" by A.M. Best [8]. Buyers should confirm the exact legal issuer on the application and policy.

This review sits inside a broader comparison of Final Expense Insurance for People With Diabetes, which covers how carriers differ on diabetes underwriting.

The Product, Model, Plan, or Service Most Relevant to Final Expense Insurance for People With Diabetes

Questions This Section Answers

  • Which Aetna product should a senior with diabetes choose for $15,000–$25,000 of permanent final expense coverage?
  • Does Aetna Accendo Final Expense Whole Life require a medical exam for applicants with diabetes?

The relevant product is Accendo Final Expense Whole Life Insurance, a simplified-issue permanent whole life policy with Level/Preferred, Standard, and Modified benefit options [9]. Company materials describe permanent whole life features, level and modified benefits, face amounts, policy fees, riders, payment options, cash value, and policy-loan provisions [9]. Independent summaries describe it as simplified-issue whole life with Preferred, Standard, and Modified plans, level premiums, an age range, face amounts, and state-specific rider variation [10].

No medical exam is required. Multiple independent reviews state that approval is based on a short health questionnaire, prescription check, and basic underwriting rather than an exam [11]. Issue ages are generally cited as 40–89 [15], and face amounts are commonly listed from $2,000 to $50,000 depending on age [18]. One source states the policy can be issued up to $35,000 for ages 45–65 and to a maximum of $25,000 for ages 66–80 [20], while another reports a $25,000 maximum for ages 76+ on Level plans [21]. Those maximums conflict across sources and should be verified for the buyer's age and state.

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about Aetna Accendo for seniors with diabetes?
  • Is Aetna Accendo considered diabetic-friendly for day-one final expense coverage?

The clearest cross-platform agreement is that Aetna/Accendo is a simplified-issue whole life product with no medical exam and a permanent structure suited to final expenses [22]. A second area of broad agreement is that the product is often described as relatively favorable for controlled diabetes. Independent sources describe it as "diabetic-friendly," with insulin not mentioned on the application and diabetes diagnosed at any age acceptable [27], and other reviews state that controlled diabetics, including many insulin users, are frequently approved for day-one level coverage [28].

A third agreement concerns benefit timing. Level, Preferred, and Standard tiers are described as paying the full death benefit from day one, while Modified coverage carries a graded or limited-benefit period [31]. A fourth agreement is that underwriting remains active after the application. Company materials state that applications are subject to underwriting until issue and first premium payment, with prescription-drug and MIB reviews and possible plan changes or ineligibility [34].

These agreements describe how platforms characterized the product. They do not establish that Aetna will approve any particular diabetic applicant or that its pricing is competitive.

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • Do AI platforms disagree about how strict Aetna is on diabetes underwriting?
  • Is Aetna Accendo available in every state for final expense coverage?

Platforms disagreed on how strict Aetna is on diabetes. One independent review states that Aetna's underwriting may be "slightly stricter regarding diabetes" compared to another carrier offering a level benefit plan [36], while multiple other sources describe Accendo as diabetic-friendly and accepting diabetes at Standard or Preferred rates [38]. The stricter-underwriting claim did not include specific supporting evidence in the supplied material.

Platforms also disagreed on state availability. One platform states the product is available in all states except New York [41], while another states it is unavailable in Massachusetts, New York, and Rhode Island [42]. A third notes that the separate Protection Series product is not offered in 10 states and has tighter underwriting for insulin-dependent diabetes [43]. The supplied evidence does not resolve which state list is correct.

Several items remain uncertain across platforms. The reviewed public sources do not verify current 2026 diabetes rules for Type 1 diabetes, insulin use, A1C levels, diagnosis age, or specific diabetes medications [45]. One platform states that Type 1 diabetes eligibility for day-one level coverage is not explicitly confirmed [48]. Another notes that while marketing materials say there are no insulin questions, automated underwriting scans prescription databases that will reveal insulin use [49]. Benefit maximums also conflict, with sources citing different caps by age [50].

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What features make Aetna Accendo useful for a diabetic senior who wants immediate coverage?
  • Does Aetna Accendo offer a Modified benefit option if diabetes complications affect eligibility?

The features most relevant to this use case are simplified issue, permanent coverage, day-one benefits on Level tiers, a Modified fallback, and a fast electronic decision. Company materials describe Level and Modified benefit options within a permanent whole life structure [52]. Independent summaries describe Preferred, Standard, and Modified plans with level premiums [53]. Level and Preferred/Standard tiers are described as providing immediate full death benefits, while Modified coverage generally provides full accidental-death coverage immediately and a reduced non-accidental death benefit during the early policy years [54].

Application materials specifically ask about diabetes complications including diabetic coma, insulin shock, retinopathy, nephropathy, and neuropathy, and certain health answers may lead to Modified eligibility or ineligibility [57]. One source states that underwriting may approve applicants who have had no adjustments in diabetic medications for the last 12 months and are free of neuropathy [59]. Another states that recent adjustments or changes to diabetes medications within the last 12 months can negatively affect the underwriting decision [59].

Electronic submissions typically generate eligibility decisions quickly, allowing agents to set expectations immediately [60], and one source states that Aetna renders an underwriting decision within just a few minutes after submission [61]. Social Security Deposit Billing is available, which aligns premium withdrawals with Social Security deposit timing [62]. One platform reports a 10% premium discount for applicants who also hold an Aetna Medicare Supplement policy [64]; this is platform-reported and should be confirmed directly with Aetna.

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does Aetna Accendo final expense cost per month for $15,000–$25,000 of coverage?
  • Are there policy fees or riders that increase Aetna Accendo premiums?

No reliable public diabetes-specific premium can be stated. Available 2026 independent rate examples suggest that Accendo premiums for $15,000–$25,000 vary substantially by age, sex, tobacco status, underwriting tier, state, and payment mode [65]. Illustrative non-diabetes-specific figures include roughly $48 per month for a 65-year-old female non-smoker and $58 for a male the same age at $10,000 of Preferred (Level) coverage [66]. One independent rate table gives a sample level-plan rate of $32.50 a month at age 45, $55.83 at 65, and $286.67 at 89 for a $10,000 death benefit [68]. Another source lists $44.32 for a 65-year-old female at $10,000 [70], and a third lists $47 female and $58 male at age 65 [71]. These figures conflict and are not diabetes-specific.

On fees, published product materials identify an annual policy fee in at least one current brochure version, and the exact fee and whether it applies in the buyer's state should be confirmed [72]. Possible rider charges or administrative deductions exist, and accelerated-death-benefit use may involve an administrative deduction under published brochure terms [72]. One platform states that no separate policy fee was verified in the sources it reviewed [73], which conflicts with the brochure reference.

On contract terms, premiums must be paid to keep the policy in force, and nonpayment may trigger grace-period, loan, reduced-paid-up, or extended-term provisions depending on policy value and state law [72]. Applications remain subject to underwriting until issue and payment of the first premium [74]. Modified plans may limit non-accidental death benefits during the early policy years [72]. One platform describes Modified plans as paying premiums paid plus 10% during the first two years, then the full benefit from year three [75], and another describes a two-year graded structure returning premium plus 10% in years one and two [76]. Free-look, surrender, reinstatement, and nonforfeiture terms must be read in the issued policy and may vary by state [72].

Best Suited For

Questions This Section Answers

  • Who is Aetna Accendo best suited for among seniors with diabetes?
  • Is Aetna a good choice for a senior with well-managed Type 2 diabetes who wants day-one coverage?

Aetna/Accendo is best suited for applicants with stable or otherwise insurable diabetes who want permanent whole life coverage without a medical exam [77]. It fits applicants seeking $15,000–$25,000, which is generally within the published face-amount range for many ages, subject to state and age limits [77]. It also fits applicants who may need a Modified benefit option because of diabetes complications or other disclosed health conditions [77].

Platforms specifically describe the best-fit profile as seniors age 50–75 with well-managed Type 1 or Type 2 diabetes, with or without insulin, and no major complications such as neuropathy, kidney disease, or cardiovascular events [81]. Older applicants who value simplified application processing and potentially immediate underwriting feedback are also a fit [84]. One platform highlights applicants aged 80–89 who need coverage and do not qualify for carriers with lower maximum ages [86].

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose Aetna Accendo for final expense insurance with diabetes?
  • Is Aetna a poor fit for a diabetic who needs guaranteed acceptance with no health questions?

Aetna is probably not best suited for applicants who need guaranteed acceptance regardless of health history. Aetna's final expense product is simplified issue, not guaranteed issue, and it still asks health questions and can decline [87]. It is also a weaker fit for applicants with significant diabetes complications, unacceptable medications, or multiple serious conditions unless a Modified or other fallback benefit is acceptable [90].

Men over age 75 face a specific limitation: one independent source states that Aetna's Standard and Modified tiers are not available to men over 75, so this group must qualify for the Preferred tier or look at a different carrier [93]. Buyers seeking the lowest possible premium without comparing individualized quotes from multiple carriers are also a poor fit, since one platform reports that Mutual of Omaha may be cheaper for the same profile [96]. Applicants who prefer fully medically underwritten coverage with potentially higher limits or more favorable pricing should look elsewhere [98].

When Another Option May Be Better

Questions This Section Answers

  • When is another carrier a better choice than Aetna for a diabetic seeking final expense coverage?
  • What is a better alternative to Aetna if diabetes is complicated by COPD or heart disease?

Another option may be better in several defined situations. If the buyer has insulin-dependent diabetes combined with other serious conditions such as COPD, advanced heart disease, or kidney disease, one independent source states that Transamerica may offer better underwriting and rate outcomes and is more lenient on combinations like insulin-dependent diabetes with COPD or heart disease with stents [99]. If the buyer needs guaranteed acceptance with no health questions, a guaranteed-issue policy from another carrier is more appropriate, since Aetna does not appear to offer a guaranteed-issue final expense product [101].

If the buyer's priority is the lowest possible premium and they qualify elsewhere, one platform reports that Mutual of Omaha may be cheaper at comparable ages [103]. If the buyer has had a diabetes-related amputation, recent hospitalization for diabetes, or dialysis, a guaranteed-issue policy from another carrier is more appropriate [101]. If the buyer needs more than the applicable Accendo age-based face-amount maximum, another carrier should be evaluated [105]. If the buyer can qualify for fully underwritten life insurance and wants to compare potentially broader coverage or different pricing, that path may be better [105].

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with Aetna before signing an Accendo final expense contract?
  • Which diabetes details does Aetna Accendo ask about on the application?

Before applying, the buyer should confirm the exact legal issuer on the policy, since the product is marketed under Aetna-related branding but the policy issuer identified in public materials is Accendo Insurance Company [107]. The buyer should ask which diabetes details appear on the application and how Type 1 or Type 2 diabetes, insulin use, diagnosis age, A1C, medication type, and recent treatment changes affect eligibility or rate class [109]. The buyer should also ask whether any diabetes complications, kidney conditions, cardiovascular conditions, or medications make the selected tier unavailable [109].

On pricing, the buyer should request the exact premium by payment mode for the desired $15,000–$25,000, including policy fees and riders [107]. The buyer should confirm whether the death benefit is full from day one for both accidental and natural death, or whether the policy is Modified, and if Modified, what exact benefit is payable for non-accidental death in policy years one and two [107]. The buyer should confirm state-specific maximum face amount, issue-age limit, free-look period, grace period, surrender, reinstatement, and nonforfeiture terms [107]. The buyer should also ask whether prescription-drug database and MIB findings are reviewed before approval and whether any preliminary approval is conditional [110], and whether an individualized Accendo quote can be compared with at least two other carriers before submitting an application [107].

Final AI Consensus Verdict

Aetna/Accendo is a good fit to investigate, not a conclusively best choice, for a senior with diabetes seeking $15,000–$25,000 of permanent final expense insurance. Four of seven platforms named it in the ranking stage, with an average listed rank of 2.75 and a best rank of 1. Six platforms rated the fit good or strong, and one rated it mixed. Its main advantages are simplified issue, broad advertised age and face-amount ranges, and a Modified fallback. The buyer should obtain a diabetes-specific prequalification or formal quote and compare it with other carriers, because the public evidence does not establish current applicant-level diabetes acceptance or pricing.

How This Review Was Produced

This review used the supplied platform fit-research responses for Aetna in the Final Expense Insurance for People With Diabetes use case. Seven platforms evaluated fit, and four named Aetna during ranking discovery. The study date is 2026-09-22. Platform-reported research dates were 2026-09-23 and are provenance metadata only; they do not independently prove freshness. Citations are platform-reported evidence, not independently verified facts. The supplied URLs were collected from platform responses and were not independently validated by the writer stage. No personal testing, customer experience, or independent verification was performed.

Methodology Limitations

Platform-reported research dates differ from the authoritative run date, and those dates do not independently prove freshness. Platform mentions count only platforms that named the entity during ranking discovery; all included platforms evaluated fit. Conflicting product names, pricing, and capabilities were described rather than resolved, and buyers should verify them directly. The deterministic identity audit collapsed company-name variants onto one canonical brand before minimum-mentions qualification, and official-site retrieval failed for one or more mentions, so no failed fetch was used as a verified domain key. The reviewed public sources do not verify current 2026 diabetes rules for Type 1 diabetes, insulin use, A1C levels, diagnosis age, or specific diabetes medications. Public premium examples are illustrative, non-diabetes-specific, and not a substitute for an issued illustration or quote. Availability, riders, fees, face-amount limits, and policy provisions may vary by state and may change. AI-platform agreement does not prove product quality.

Sources

Company-Owned Sources

  • Life Insurance for Diabetics: What to Know: https://www.progressive.com/answers/life-insurance-for-diabetics/
  • Official pricing and terms source: https://www.aetna.com/
  • Official pricing and terms source: https://www.aetna.com/#Find
  • Additional AI research evidence115 records
    1. AI research evidence record openai:c1
    2. AI research evidence record anthropic:1-1
    3. AI research evidence record deepseek:c2
    4. AI research evidence record grok:0
    5. AI research evidence record anthropic:1-4
    6. AI research evidence record anthropic:1-6
    7. AI research evidence record anthropic:22-4
    8. AI research evidence record anthropic:6-5
    9. AI research evidence record openai:c1
    10. AI research evidence record openai:c6
    11. AI research evidence record anthropic:7-2
    12. AI research evidence record anthropic:22-9
    13. AI research evidence record anthropic:23-3
    14. AI research evidence record anthropic:24-9
    15. AI research evidence record anthropic:2-15
    16. AI research evidence record anthropic:5-12
    17. AI research evidence record anthropic:7-3
    18. AI research evidence record anthropic:18-7
    19. AI research evidence record anthropic:25-1
    20. AI research evidence record anthropic:20-5
    21. AI research evidence record grok:0
    22. AI research evidence record openai:c1
    23. AI research evidence record anthropic:1-1
    24. AI research evidence record deepseek:c1
    25. AI research evidence record grok:0
    26. AI research evidence record perplexity:c5
    27. AI research evidence record anthropic:2-1
    28. AI research evidence record deepseek:c2
    29. AI research evidence record kimi:theburialinsurance-1
    30. AI research evidence record grok:7
    31. AI research evidence record anthropic:6-17
    32. AI research evidence record anthropic:25-16
    33. AI research evidence record perplexity:c8
    34. AI research evidence record openai:c4
    35. AI research evidence record perplexity:c2
    36. AI research evidence record anthropic:12-2
    37. AI research evidence record anthropic:12-10
    38. AI research evidence record anthropic:2-11
    39. AI research evidence record anthropic:2-12
    40. AI research evidence record deepseek:c3
    41. AI research evidence record grok:0
    42. AI research evidence record google:1.1.2
    43. AI research evidence record anthropic:6-4
    44. AI research evidence record anthropic:16-3
    45. AI research evidence record openai:c3
    46. AI research evidence record openai:c4
    47. AI research evidence record openai:c5
    48. AI research evidence record kimi:rycolifesolutions-4
    49. AI research evidence record google:1.1.4
    50. AI research evidence record anthropic:20-5
    51. AI research evidence record perplexity:c3
    52. AI research evidence record openai:c1
    53. AI research evidence record openai:c6
    54. AI research evidence record anthropic:6-17
    55. AI research evidence record anthropic:25-16
    56. AI research evidence record perplexity:c8
    57. AI research evidence record openai:c3
    58. AI research evidence record google:2.1.8
    59. AI research evidence record google:2.2.6
    60. AI research evidence record anthropic:5-3
    61. AI research evidence record anthropic:10-19
    62. AI research evidence record anthropic:2-14
    63. AI research evidence record anthropic:5-5
    64. AI research evidence record google:2.1.7
    65. AI research evidence record openai:c2
    66. AI research evidence record anthropic:22-1
    67. AI research evidence record anthropic:22-2
    68. AI research evidence record anthropic:20-1
    69. AI research evidence record anthropic:20-2
    70. AI research evidence record deepseek:c1
    71. AI research evidence record kimi:asurgo-2
    72. AI research evidence record openai:c1
    73. AI research evidence record perplexity:c2
    74. AI research evidence record openai:c4
    75. AI research evidence record anthropic:1-13
    76. AI research evidence record grok:0
    77. AI research evidence record openai:c1
    78. AI research evidence record anthropic:1-1
    79. AI research evidence record anthropic:18-7
    80. AI research evidence record anthropic:6-17
    81. AI research evidence record anthropic:2-1
    82. AI research evidence record anthropic:2-11
    83. AI research evidence record kimi:theburialinsurance-1
    84. AI research evidence record anthropic:5-3
    85. AI research evidence record anthropic:10-19
    86. AI research evidence record kimi:asurgo-3
    87. AI research evidence record deepseek:c5
    88. AI research evidence record deepseek:c7
    89. AI research evidence record kimi:theburialinsurance-1
    90. AI research evidence record openai:c3
    91. AI research evidence record anthropic:3-3
    92. AI research evidence record anthropic:3-4
    93. AI research evidence record anthropic:3-5
    94. AI research evidence record anthropic:3-6
    95. AI research evidence record anthropic:3-7
    96. AI research evidence record deepseek:c1
    97. AI research evidence record kimi:asurgo-2
    98. AI research evidence record openai:c1
    99. AI research evidence record anthropic:3-3
    100. AI research evidence record anthropic:3-4
    101. AI research evidence record deepseek:c6
    102. AI research evidence record kimi:theburialinsurance-1
    103. AI research evidence record deepseek:c1
    104. AI research evidence record kimi:asurgo-2
    105. AI research evidence record openai:c1
    106. AI research evidence record anthropic:20-5
    107. AI research evidence record openai:c1
    108. AI research evidence record anthropic:1-4
    109. AI research evidence record openai:c3
    110. AI research evidence record openai:c4
    111. AI research evidence record google:2.1.8
    112. AI research evidence record anthropic:3-3
    113. AI research evidence record openai:c2
    114. AI research evidence record anthropic:6-17
    115. AI research evidence record perplexity:c2

Independent Sources

Other Sources

  • Additional AI research evidence115 records
    1. AI research evidence record openai:c1
    2. AI research evidence record anthropic:1-1
    3. AI research evidence record deepseek:c2
    4. AI research evidence record grok:0
    5. AI research evidence record anthropic:1-4
    6. AI research evidence record anthropic:1-6
    7. AI research evidence record anthropic:22-4
    8. AI research evidence record anthropic:6-5
    9. AI research evidence record openai:c1
    10. AI research evidence record openai:c6
    11. AI research evidence record anthropic:7-2
    12. AI research evidence record anthropic:22-9
    13. AI research evidence record anthropic:23-3
    14. AI research evidence record anthropic:24-9
    15. AI research evidence record anthropic:2-15
    16. AI research evidence record anthropic:5-12
    17. AI research evidence record anthropic:7-3
    18. AI research evidence record anthropic:18-7
    19. AI research evidence record anthropic:25-1
    20. AI research evidence record anthropic:20-5
    21. AI research evidence record grok:0
    22. AI research evidence record openai:c1
    23. AI research evidence record anthropic:1-1
    24. AI research evidence record deepseek:c1
    25. AI research evidence record grok:0
    26. AI research evidence record perplexity:c5
    27. AI research evidence record anthropic:2-1
    28. AI research evidence record deepseek:c2
    29. AI research evidence record kimi:theburialinsurance-1
    30. AI research evidence record grok:7
    31. AI research evidence record anthropic:6-17
    32. AI research evidence record anthropic:25-16
    33. AI research evidence record perplexity:c8
    34. AI research evidence record openai:c4
    35. AI research evidence record perplexity:c2
    36. AI research evidence record anthropic:12-2
    37. AI research evidence record anthropic:12-10
    38. AI research evidence record anthropic:2-11
    39. AI research evidence record anthropic:2-12
    40. AI research evidence record deepseek:c3
    41. AI research evidence record grok:0
    42. AI research evidence record google:1.1.2
    43. AI research evidence record anthropic:6-4
    44. AI research evidence record anthropic:16-3
    45. AI research evidence record openai:c3
    46. AI research evidence record openai:c4
    47. AI research evidence record openai:c5
    48. AI research evidence record kimi:rycolifesolutions-4
    49. AI research evidence record google:1.1.4
    50. AI research evidence record anthropic:20-5
    51. AI research evidence record perplexity:c3
    52. AI research evidence record openai:c1
    53. AI research evidence record openai:c6
    54. AI research evidence record anthropic:6-17
    55. AI research evidence record anthropic:25-16
    56. AI research evidence record perplexity:c8
    57. AI research evidence record openai:c3
    58. AI research evidence record google:2.1.8
    59. AI research evidence record google:2.2.6
    60. AI research evidence record anthropic:5-3
    61. AI research evidence record anthropic:10-19
    62. AI research evidence record anthropic:2-14
    63. AI research evidence record anthropic:5-5
    64. AI research evidence record google:2.1.7
    65. AI research evidence record openai:c2
    66. AI research evidence record anthropic:22-1
    67. AI research evidence record anthropic:22-2
    68. AI research evidence record anthropic:20-1
    69. AI research evidence record anthropic:20-2
    70. AI research evidence record deepseek:c1
    71. AI research evidence record kimi:asurgo-2
    72. AI research evidence record openai:c1
    73. AI research evidence record perplexity:c2
    74. AI research evidence record openai:c4
    75. AI research evidence record anthropic:1-13
    76. AI research evidence record grok:0
    77. AI research evidence record openai:c1
    78. AI research evidence record anthropic:1-1
    79. AI research evidence record anthropic:18-7
    80. AI research evidence record anthropic:6-17
    81. AI research evidence record anthropic:2-1
    82. AI research evidence record anthropic:2-11
    83. AI research evidence record kimi:theburialinsurance-1
    84. AI research evidence record anthropic:5-3
    85. AI research evidence record anthropic:10-19
    86. AI research evidence record kimi:asurgo-3
    87. AI research evidence record deepseek:c5
    88. AI research evidence record deepseek:c7
    89. AI research evidence record kimi:theburialinsurance-1
    90. AI research evidence record openai:c3
    91. AI research evidence record anthropic:3-3
    92. AI research evidence record anthropic:3-4
    93. AI research evidence record anthropic:3-5
    94. AI research evidence record anthropic:3-6
    95. AI research evidence record anthropic:3-7
    96. AI research evidence record deepseek:c1
    97. AI research evidence record kimi:asurgo-2
    98. AI research evidence record openai:c1
    99. AI research evidence record anthropic:3-3
    100. AI research evidence record anthropic:3-4
    101. AI research evidence record deepseek:c6
    102. AI research evidence record kimi:theburialinsurance-1
    103. AI research evidence record deepseek:c1
    104. AI research evidence record kimi:asurgo-2
    105. AI research evidence record openai:c1
    106. AI research evidence record anthropic:20-5
    107. AI research evidence record openai:c1
    108. AI research evidence record anthropic:1-4
    109. AI research evidence record openai:c3
    110. AI research evidence record openai:c4
    111. AI research evidence record google:2.1.8
    112. AI research evidence record anthropic:3-3
    113. AI research evidence record openai:c2
    114. AI research evidence record anthropic:6-17
    115. AI research evidence record perplexity:c2

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 22, 2026
Platforms analyzed
7
Source records
43
Ranking mentions
4 of 7
Platform share
57%
Final consensus rank
#6

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

32 independent · 10 company-owned · 1 unclear

Evidence support

24 direct · 16 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

bb367f3fb427e873a70dc91b52b9ea4aa8a12b1e041f324d3b15e856fec2034b